Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine wound infiltration with ketamine or magnesium versus bupivacaine alone after cesarean section
PACTR202607539615815Phase 1Not yet recruiting
- Sponsor
- Dr Ayodeji Oluwatominiyi
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of bupivacaine, ketamine and magnesium sulfate in postoperative pain, sponsored by Dr Ayodeji Oluwatominiyi. Primary endpoint: Postoperative pain score. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
bupivacaineketaminemagnesium sulfate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202607539615815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202607539615815.